ArticleJournal of the American Chemical Society2024

Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.

Eric D Huseman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.